Stocks and Investing
Stocks and Investing
Fri, May 28, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, May 27, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Michelle Gilson Maintained (TVTX) at Strong Buy with Decreased Target to $45 on, May 27th, 2021
Michelle Gilson of Canaccord Genuity, Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Decreased Target from $48 to $45 on, May 27th, 2021.
Michelle has made no other calls on TVTX in the last 4 months.
There is 1 other peer that has a rating on TVTX. Out of the 1 peers that are also analyzing TVTX, all agrees with Michelle's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Laura Chico of "Wedbush" Downgraded from Buy to Hold and Held Target at $19 on, Wednesday, May 26th, 2021
Contributing Sources